SOLICITATION NOTICE
99 -- Retinal Image-Based Diagnosis of Disease
- Notice Date
- 11/3/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Energy, Oak Ridge National Laboratory - UT Battelle LLC (DOE Contractor), Oak Ridge National Laboratory, Bethel Valley Road, P.O. Box 2008, Oak Ridge, Tennessee, 37831-6192
- ZIP Code
- 37831-6192
- Solicitation Number
- ORNL-OTT-2010-1
- Archive Date
- 12/18/2009
- Point of Contact
- Mark Reeves, Phone: 8655762577
- E-Mail Address
-
reevesme@ornl.gov
(reevesme@ornl.gov)
- Small Business Set-Aside
- N/A
- Description
- TECHNOLOGY/BUSINESS OPPORTUNITY Retinal Image-Based Diagnosis of Disease Opportunity: UT-Battelle, LLC, the management and operating contractor for the Department of Energy's (DOE) Oak Ridge National Laboratory, is offering the opportunity, for one or more industrial partners to license and commercialize UT‑Battelle's Retinal Image-Based Diagnosis of Disease technology. Background: The Oak Ridge National Laboratory (ORNL) has been involved in research on computer-based image analysis for the past 15+ years, with both government agencies and private companies. Programs have been undertaken with organizations such as the U.S. Department of Energy, the National Eye Institute, SEMATECH, and various private partners. Applications have included geospatial imaging, quality control in semiconductor chip manufacturing, and human health monitoring. Description: This is a technology for the rapid, computer-assisted diagnosis of blinding eye disease. Specifically, it is a method that measures image content from diagnosed patient data in a large patient archive to make a statistical diagnosis of the degree of disease state that may exist in a previously undiagnosed patient and the characterization of the disease type. The Retinal Image-Based Diagnosis of Disease technology is focused on improving access to retinal screening by at-risk patients in large numbers without need for a formal visit to an ophthalmologist. The technology is based on computer algorithms to analyze retinal images from fundus cameras and compare those images with an archive of similar images with confirmed diagnoses of state of (or absence of) disease. The technology applies to a broad range of human retinal pathologies provided they impact the pigmentation of the retina or the morphology of major retinal structures such as the optic disc, macula/fovea regions, and the vascular arcades. Its potential applications include diagnosis of human retinal pathologies related to (1) retinal pigmentation; (2) retinal structures; and (3) diabetic retinopathy. Advantages: The Retinal Image-Based Diagnosis of Disease technology ORNL developed has the potential to provide the following advantages over currently available technologies: (1) reliable diagnosis in much less time than the reading center model; (2) inexpensive analysis and diagnosis enabling services in rural and third world communities; and (3) productive use of the historical record of digital fundus imagery collected by the medical community. Development Status: The Retinal Image-Based Diagnosis of Disease technology has been developed to the proof-of-principle stage, but no prototypes or working models exist at ORNL. In addition to the pending U.S. patent, a copyrighted software package implementing the necessary algorithms is also part of the intellectual property available for licensing. Intellectual Property Status: ORNL Retinal Image-Based Diagnosis of Disease technology embedded in the following pieces of UT-Battelle Intellectual Property: Invention Disclosure Number 1596, "Method and System for the Diagnosis of Disease Using Retinal Image Content and an Archive of Diagnosed Human Patient Data (patent pending-U.S. Patent Application No. US 2007/0258630 A1 published November 8, 2007); Copyrighted software implementing the algorithms necessary to enable the technology (copyright registration pending with Library of Congress). Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing UT-Battelle's Retinal Image-Based Diagnosis of Disease technology should provide a written statement of interest that includes: •1. Company name and address •2. Name, address, and telephone number of a point of contact •3. Description of corporate capabilities and experience relevant to commercializing the technology. Written responses should be directed to: Dr. Mark Reeves, Deputy Director Office of Technology Transfer Oak Ridge National Laboratory/UT-Battelle, LLC P.O. Box 2008 One Bethel Valley Road Oak Ridge, Tennessee 37831-6196 Voice: (865) 576-2577 FAX: (865) 574-9241 E-mail: reevesme@ornl.gov Please provide your written statement within thirty (30) days from the date this announcement is published to ensure consideration of your interest in commercializing UT-Battelle's Retinal Image-Based Diagnosis of Disease technology.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DOE/ORNL/ORNL/ORNL-OTT-2010-1/listing.html)
- Record
- SN01997226-W 20091105/091103235210-057353f2da993d637f1d95efb214e623 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |